Cross Infection

The grounding supports infectious agents acquired in healthcare settings as the proximate cause, but does not provide a single underlying aetiology beyond transmission of nosocomial pathogens. It also notes that inanimate surfaces can serve as sources for outbreaks, indicating environmental contamination as one route of acquisition.

The literature emphasizes persistence of nosocomial pathogens on dry inanimate surfaces and their transmission within healthcare environments. It also highlights bacterial drug resistance, including multidrug resistance, as a major feature of important nosocomial organisms and a contributor to ongoing infection and control difficulty.

Hospitalization and care in healthcare institutions are inherent risk contexts, and the reviewed guidelines specifically address patients at risk for hospital-acquired and ventilator-associated pneumonia. Environmental persistence of pathogens on inanimate surfaces and the presence of multidrug-resistant nosocomial bacteria are also supported as factors associated with acquisition and spread.

Management is described at the level of prevention and control, diagnosis, and drug therapy for nosocomial infections such as hospital-acquired and ventilator-associated pneumonia. The grounding also supports antimicrobial treatment guided by concern for resistant organisms, alongside infection-control measures to limit transmission in healthcare settings.